Variant report
Variant | nsv471159 |
---|---|
Chromosome Location | chr13:85283911-85337948 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554866438 | chr13:85303430-85303431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs146680879 | chr13:85303447-85303448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374766752 | chr13:85303470-85303471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540572014 | chr13:85303505-85303506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565147433 | chr13:85303512-85303513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538575192 | chr13:85303529-85303530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192466607 | chr13:85303533-85303534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs140245529 | chr13:85303595-85303596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145203201 | chr13:85303638-85303639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550802890 | chr13:85303640-85303641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575899715 | chr13:85303665-85303666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72629467 | chr13:85303685-85303686 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs530216983 | chr13:85303687-85303688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548390958 | chr13:85303714-85303715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9670615 | chr13:85303735-85303736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs535837247 | chr13:85303768-85303769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552873201 | chr13:85303770-85303771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571152830 | chr13:85303775-85303776 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550615507 | chr13:85304616-85304617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568923976 | chr13:85304660-85304661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181702677 | chr13:85304700-85304701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149015070 | chr13:85304722-85304723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371597138 | chr13:85304723-85304724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190569592 | chr13:85305019-85305020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376501916 | chr13:85305037-85305038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376062881 | chr13:85305086-85305087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200030010 | chr13:85305088-85305089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9602542 | chr13:85305109-85305110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541916383 | chr13:85305120-85305121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs560663501 | chr13:85305147-85305148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs180982924 | chr13:85305198-85305199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143817714 | chr13:85305212-85305213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529234438 | chr13:85305228-85305229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564593936 | chr13:85305262-85305263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543021284 | chr13:85305301-85305302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550551933 | chr13:85305371-85305372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562461536 | chr13:85305372-85305373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61960236 | chr13:85305386-85305387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528609156 | chr13:85305409-85305410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547958454 | chr13:85305451-85305452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs537457777 | chr13:85305462-85305463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533714891 | chr13:85305526-85305527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375191339 | chr13:85305618-85305619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185300784 | chr13:85305668-85305669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs537759423 | chr13:85305681-85305682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs77864962 | chr13:85305687-85305688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559858180 | chr13:85305689-85305690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540700233 | chr13:85305708-85305709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148151562 | chr13:85305741-85305742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564933071 | chr13:85305772-85305773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 20502679 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85303400-85303800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr13:85304600-85304800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr13:85304600-85304800 | Enhancers | Fetal Lung | lung |
4 | chr13:85305000-85306200 | Weak transcription | Fetal Lung | lung |
5 | chr13:85305200-85306200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr13:85306200-85306400 | Enhancers | Fetal Lung | lung |
7 | chr13:85306200-85306600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr13:85306200-85307000 | Enhancers | Brain Germinal Matrix | brain |
9 | chr13:85306400-85306800 | Weak transcription | Fetal Lung | lung |
10 | chr13:85306800-85307200 | Enhancers | Fetal Lung | lung |
11 | chr13:85309400-85309600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr13:85309600-85311600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
13 | chr13:85310800-85312800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr13:85311000-85312400 | Enhancers | Primary hematopoietic stem cells | blood |
15 | chr13:85311000-85312800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr13:85311600-85312000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr13:85311600-85312000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
18 | chr13:85311800-85312200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
19 | chr13:85312800-85315400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
20 | chr13:85315400-85315800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
21 | chr13:85315800-85318400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
22 | chr13:85318400-85318800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
23 | chr13:85322800-85323800 | Enhancers | Fetal Heart | heart |
24 | chr13:85323400-85324000 | Enhancers | Fetal Lung | lung |
25 | chr13:85330600-85331400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |